NewAmsterdam Pharma Company N.V. NAMS
NASDAQ · United States · Health Technology
$24.51+0.18 (+0.76%)
Market open· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Market open· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
| Quarter | Report date | Actual EPS | Estimated EPS | EPS surprise | Actual revenue | Revenue surprise | Price reaction |
|---|---|---|---|---|---|---|---|
| Q2 2026 | 2026-08-05 | -0.52 | -0.48 | -9.0% | $3.70M | +97.2% | +0.4%$27.55→$27.67 |
| Q1 2026 | 2026-05-07 | -0.40 | -0.46 | +13.0% | — | — | +25.0%$30.99→$38.73 |
| Q4 2025 | 2026-02-18 | -0.53 | -0.37 | -43.2% | — | — | -1.7%$35.24→$34.63 |
| Q3 2025 | 2025-11-05 | -0.41 | -0.38 | -7.9% | — | — | +1.4%$36.53→$37.05 |
| Q4 2024 | 2025-02-26 | -0.90 | -0.47 | -91.5% | — | — | — |
The price reaction is the change from the last close before the announcement date to the first close after it - the report may land before the open, during the session or after the close, so this window covers all three. Not investment advice.